Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling - Wikidata - awgldk - TriplyDB

Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling

Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling

http://www.wikidata.org/entity/Q35009476

about

Leishmania RNA virus: when the host pays the toll Management of immunosuppressant agents following liver transplantation: Less is more RNA mediated Toll-like receptor stimulation in health and disease Toll like receptor 3 plays a critical role in the progression and severity of acetaminophen-induced hepatotoxicity Type I interferon receptor deficiency prevents murine Sjogren's syndrome Development of a spontaneous liver disease resembling autoimmune hepatitis in mice lacking tyro3, axl and mer receptor tyrosine kinases The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids.Helminth cysteine proteases inhibit TRIF-dependent activation of macrophages via degradation of TLR3.Systemic administration of TLR3 agonist induces IL-7 expression and IL-7-dependent CXCR3 ligand production in the lung.Hepatic gene transfer as a means of tolerance induction to transgene products Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection AAV vectors avoid inflammatory signals necessary to render transduced hepatocyte targets for destructive T cells Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.Different toll-like receptor stimuli have a profound impact on cytokines required to break tolerance and induce autoimmunity Toll-like receptor 3 in liver diseases.Adeno-associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them.Liver restores immune homeostasis after local inflammation despite the presence of autoreactive T cells.Immunization with a recombinant vaccinia virus that encodes nonstructural proteins of the hepatitis C virus suppresses viral protein levels in mouse liver Sequence- and target-independent angiogenesis suppression by siRNA via TLR3 Usp18 driven enforced viral replication in dendritic cells contributes to break of immunological tolerance in autoimmune diabetes.Antigen-driven focal inflammatory death of malaria liver stages NKG2D recognition mediates Toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice Innate Immune Signaling Induces IL-7 Production, Early Inflammatory Responses, and Sjögren's-Like Dacryoadenitis in C57BL/6 Mice.Activation of Toll-like receptor 3 amplifies mesenchymal stem cell trophic factors and enhances therapeutic potency.Sensing of viral infection and activation of innate immunity by toll-like receptor 3 Sex-specific signaling through Toll-Like Receptors 2 and 4 contributes to survival outcome of Coxsackievirus B3 infection in C57Bl/6 mice.Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection.Experimental coronavirus retinopathy (ECOR): retinal degeneration susceptible mice have an augmented interferon and chemokine (CXCL9, CXCL10) response early after virus infection.TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events Interferon-γ facilitates hepatic antiviral T cell retention for the maintenance of liver-induced systemic tolerance.Autoimmunity stimulated by adoptively transferred dendritic cells is initiated by both alphabeta and gammadelta T cells but does not require MyD88 signaling.MyD88 intrinsically regulates CD4 T-cell responses Immunotherapy for liver tumors: present status and future prospects.Inflammatory regulation by TLR3 in acute hepatitis Toll-like receptor 3 expressing tumor parenchyma and infiltrating natural killer cells in hepatocellular carcinoma patients.Increased expression of Toll-like receptor 3 in intrahepatic biliary epithelial cells at sites of ductular reaction in diseased livers Presentation of Autoantigen in Peripheral Lymph Nodes Is Sufficient for Priming Autoreactive CD8+ T Cells.Association between TLR3 rs3775291 and resistance to HIV among highly exposed Caucasian intravenous drug users Liver antigen-presenting cells.Toll-like receptor 3 in viral pathogenesis: friend or foe?

P2860

Q21131306-11F0881A-4B10-49D9-A5F5-35A2CE9623BD Q26770033-20A803D2-5C2C-4509-9909-B2E002AE2A5B Q26999252-8B7617FA-9BF5-4EE8-B666-9D30604B0A3D Q27316003-589515C9-8F9C-47F8-A7CF-289A1C609394 Q30413385-5D278AE2-2E81-4CB4-B416-80E9D5E5C548 Q31121156-83DBB92E-9BF4-4DA1-A018-9726B059C50E Q33294346-E7DB1704-0E48-4299-9447-A09FA9BF475B Q33661711-50976757-9F96-4CBA-8AAF-D735B3440955 Q33730296-19B6C25E-403E-4270-8BDC-6C807F9D66FC Q33775537-4BD7D905-E8C9-42FA-9414-F67425058D0F Q33896690-C988211D-A174-4826-A525-0BBEEE51C339 Q33931609-64B4FF83-615D-4331-A420-73BC4C988648 Q33943907-22D40EB7-D407-483F-BC31-D801E0DE8EBF Q34023191-1A825014-54CA-4742-ABC2-59115F4C0B0D Q34170010-3464BC92-5B10-455E-B78A-73EA392F6FF2 Q34370111-3A86F026-43FA-4050-92B0-80441FAF344A Q34461060-1AF30837-9CFB-483E-8A69-608BDBD5B7D5 Q34532114-70AC0CF1-5B77-4BB0-AEE4-25B87A199D30 Q34764750-DD9AB7EE-D3F2-47B2-A2B2-7530D153BBD4 Q35034181-0037E94B-644F-4C7C-BFFF-519C8EEFC249 Q35048008-A5F2B297-B6C1-4387-A533-50CE819353C2 Q35778154-E2F288BC-07CB-4D1E-BCF8-44DA3DAA0FBA Q36380242-0FA8B201-3338-471B-9FBE-9DAC11121A24 Q36382445-8CC321DB-D61D-4EFB-95C7-0F3F7351D6F8 Q36422519-F588B1E1-2461-457B-B571-3F6F7CF514D5 Q36650918-99515BF5-B2C5-4A7B-9E37-16D8D8DF29C9 Q36853435-219DF5A1-1E07-4FE1-BCD3-B2AE309FC0A4 Q36925396-762A7762-8B85-442C-A867-0666BAD93FB6 Q36946570-E37A0A09-57AA-4C32-9A0A-7C0479ADA9C5 Q36949899-5CAACEBD-41BE-486C-96D4-55E7420535D6 Q37012870-4E1E2C38-B9AC-4D8B-AD54-16AFFA19EB1B Q37099777-43D9AD67-4743-4EAB-AF6D-21412C780487 Q37144014-40FF7E16-F826-47B9-BC6A-F22F31709D90 Q37209443-4D4372A7-AA3C-42AD-AEA9-0C3626FD8E73 Q37270812-BEBC3F62-AA28-41A2-A104-15B29D666BA3 Q37278147-A3B44117-A543-4535-9236-E7C7EAF1A135 Q37634704-6055D7A3-FC62-4EA9-BE00-473458FDA195 Q37725740-3E66BDA5-477C-416E-A277-3DEBA2A61C48 Q37810357-E334C5F1-76F3-47F3-A1B7-DFF18B9BCBDA Q38126062-490E3752-0F55-4E86-8D7F-1FC9724FE4B5

P2860

Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling

http://www.wikidata.org/entity/Q35009476

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling

@ast

Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling

@en

type

label

Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling

@ast

Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling

@en

prefLabel

Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling

@ast

Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling

@en

P1433

Q35009476-2E14EF21-0D8B-40BE-A2F8-F437195AD5DB

P1476

Q35009476-7F905EB4-2D1A-4537-B155-0F223176EC62

P2093

Q35009476-01430CB9-240A-4C1D-8BB9-6B58EA05A7DF

Q35009476-101E097F-6BD8-41F2-96E6-D2D7A74015B9

Q35009476-1A63BC11-7B7C-482E-A90A-34C2F5306A27

Q35009476-26994F47-B84E-4628-850A-D439BD5134D4

Q35009476-2E4B3E2A-6AB0-4592-AA9D-A2A705F6C061

Q35009476-4A989ECD-484D-42CD-A556-DBB9A3C02286

Q35009476-555750B7-5ACC-49B9-BC34-C32E2F8365EF

Q35009476-6EAD2FC2-5CDB-45C0-AF68-F0864520B93D

Q35009476-A5CD38EC-A1FE-4212-B165-A8B67A6038D4

Q35009476-B3326889-20F3-45A2-B851-CC07D0020F94

P2860

Q35009476-06803006-E49E-4C9D-9FF0-89DDD28A6E1E

Q35009476-09B775A3-4740-40F4-8E76-91CE7D6D31DE

Q35009476-0ADA20E4-AB18-473B-A632-3B7C58ADE557

Q35009476-0DEE0CBF-4BD0-4846-9EB4-C0468A3783B4

Q35009476-13D40BC3-3DDF-41CA-A286-FB372DCB03E8

Q35009476-1AB4F6D4-B4FA-413E-ADBB-60403A4AA697

Q35009476-1D7155DE-1F50-4F5C-A212-773F25162AC6

Q35009476-231DC3AD-3993-4061-BD6D-4F530207F94F

Q35009476-2A795F9C-EB37-42FC-AE7C-5A47FD77F908

Q35009476-364B0722-A8A8-4852-8B89-CDD09DFF44CB

P304

Q35009476-B00DA4D8-4726-4877-98D5-81CD4BFBD1C1

P31

Q35009476-AB424DB9-EF99-4E4E-A7A4-0CDFFFF1AB62

P356

Q35009476-BD9C983D-9C2E-48E0-938B-6425555C9D38

P407

Q35009476-C41795F9-C507-494E-A985-544E3B7DE088

P433

Q35009476-25AB0FF3-9870-475F-BBCF-34073595CE82

P478

Q35009476-7D45D656-60BE-4D31-A276-1C1B6706E0DC

P50

Q35009476-2839E03C-AD11-46A5-A115-EC8D0F5083F2

Q35009476-9EAF6AF5-5F9B-470A-B268-2ADF8F73A1C0

Q35009476-F67F9652-A156-41BA-AC22-8C4CB4A99D78

Q35009476-FB460A3B-8D18-4325-89F1-EA385D1F3373

P577

Q35009476-A3888D34-6F37-4371-8438-DDB471F19D1A

P698

Q35009476-32CE2D2E-4C16-496E-AD0C-D5F2E97F806C

P921

Q35009476-B3819E95-E829-41BA-80DA-AAC3B98EEF19

P932

Q35009476-25A26A65-70D0-42D9-BDCB-D4B3A9127CA9

P356

P1433

Journal of Clinical Investigation

P1476

Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling

@en

P2093

Alexander A Navarini

http://www.w3.org/2001/XMLSchema#string

Andreas Bergthaler

http://www.w3.org/2001/XMLSchema#string

Bernhard Odermatt

http://www.w3.org/2001/XMLSchema#string

Hans Hengartner

http://www.w3.org/2001/XMLSchema#string

Hanspeter Pircher

http://www.w3.org/2001/XMLSchema#string

Karl S Lang

http://www.w3.org/2001/XMLSchema#string

Mike Recher

http://www.w3.org/2001/XMLSchema#string

Nicola L Harris

http://www.w3.org/2001/XMLSchema#string

Panco Georgiev

http://www.w3.org/2001/XMLSchema#string

Rolf M Zinkernagel

http://www.w3.org/2001/XMLSchema#string

P2860

Toll-like receptor signalling

CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis

Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis.

Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells.

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.

Dancing to the tune of chemokines.

Autoimmune hepatitis. Making sense of all those antibodies.

P304

2456-2463

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI28349

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

Pierre-Alain Clavien

Mathias Heikenwalder

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16955143

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

1555644

http://www.w3.org/2001/XMLSchema#string